Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex for Muscle Function After Standard Recovery (TOF 0.9)
NCT01101139Phase 4Completed
- Sponsor
- Technical University of Munich
- Start
- Apr 2010
- Primary completion
- May 2011
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Technical University of Munich. Started Apr 2010; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT01101139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01101139.